fashion -WSS

fashion

author：fashion 2025-09-06 03:15:19 - browse：3

A purple number 3 with an eye is surrounded by smaller, black number 3s on a green background — 3 to watch coverage from STAT — Christine Kao/STAT

Every winter, like Punxsutawney nobles, biotech’s many thought leaders gather for the J.P. Morgan Healthcare Conference to pick apart the year that was and prognosticate about the one to come. The consensus, in good markets and bad, is almost always cautious optimism for boom times ahead, a prediction that in recent years has had groundhog-level accuracy.

But after two years of steady decline, 2024 might finally prove them right. Biotech is on the upswing, driven by the rise of some headline-grabbing medicines, the advance of cutting-edge technologies, and a few reminders that big drug companies are still willing to pay billions of dollars for small ones.

Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： After a decade, new Gardasil ad campaign gets it (mostly) right

Wikipedia

WSS

Mystery swirls around US soldier who entered North Korea days ago, officials say

Roivant's CEO is a star, but biotech's black hole persists

Scientists grapple with ethics of stem cell research

Mystery swirls around US soldier who entered North Korea days ago, officials say

J&J lung cancer data amount to new salvo against AstraZeneca

Is there really a nursing shortage in the U.S.?

entertainment

fashion

focus

Medicare details structure of new drug price negotiation program

After a decade, new Gardasil ad campaign gets it (mostly) right

At least 13 dead in Texas as scorching temps continue

Hormonal contraceptives don’t actually treat endometriosis

Medical leaders decry Supreme Court decision on affirmative action

Questions loom on AstraZeneca cancer drug as safety concerns ebb

In Memoriam: Notable people who died in 2023

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Drug repurposing or repositioning? The language matters

In rare move, senator releases unverified FBI source report alleging Biden bribe

focus

STAT Summit: Ending the crisis of Black deaths in the U.S.

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Scientists grapple with ethics of stem cell research

When a patient nears the end, a feared therapy can comfort

How a Boston hospital is priming medical residents to use GPT

'CMA Fest' 2023: How to watch, who is performing and more

Wikipedia

knowledge

leisure time

entertainment